QT
NRIX icon

Quantbot Technologies’s Nurix Therapeutics NRIX Stock Holding History

Quantbot Technologies’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,175
Closed -$60.2K – 2019
2025
Q4 		$60.2K Buy
+3,175
New +$45.6K ﹤0.01% 1490
2023
Q1 		– Sell
-319
Closed -$3.5K – 1896
2022
Q4 		$3.5K Sell
319
-8,281
-96% -$99.9K ﹤0.01% 1571
2022
Q3 		$112K Buy
8,600
+7,600
+760% +$120K 0.01% 1064
2022
Q2 		$12K Sell
1,000
-4,600
-82% -$52.1K ﹤0.01% 1515
2022
Q1 		$78K Buy
5,600
+3,800
+211% +$67.5K 0.01% 1099
2021
Q4 		$52K Sell
1,800
-5,200
-74% -$158K ﹤0.01% 1013
2021
Q3 		$209K Buy
7,000
+6,800
+3,400% +$210K 0.02% 799
2021
Q2 		$5K Buy
+200
New +$5.87K ﹤0.01% 1363

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Quantbot Technologies's NRIX Position: Q1 2026 in Review

Quantbot Technologies sold out of Nurix Therapeutics (NRIX) in Q1 2026, closing a stake of 3,175 shares — an estimated $60.2K sold.

Quantbot Technologies first reported a position in NRIX in Q2 2021 and held it in 8 quarters. The position peaked at $209K in Q3 2021. 195 funds tracked by Wall St. Rank hold NRIX as of Q1 2026.

  • Quantbot Technologies reported no remaining Nurix Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 3,175 Nurix Therapeutics shares in Q1 2026, an estimated $60.2K.
  • Quantbot Technologies first reported a position in Nurix Therapeutics in Q2 2021 and held it in 8 quarters.
  • Quantbot Technologies's Nurix Therapeutics position peaked at $209K in Q3 2021.
  • 195 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.